Clinical Trial Imaging Market Report 2019-2029

臨床試験イメージングの世界市場2019-2029

◆タイトル:Clinical Trial Imaging Market Report 2019-2029
◆商品コード:VGN910401
◆調査・発行会社:visiongain
◆発行日:2019年8月27日
◆ページ数:160
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Sigle UserGBP3,499 ⇒換算¥475,864見積依頼/購入/質問フォーム
Departmental/Five UserGBP3,899 ⇒換算¥530,264見積依頼/購入/質問フォーム
Site LicenseGBP4,999 ⇒換算¥679,864見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"臨床試験イメージングの世界市場2019-2029"について調査・分析し、レポートサマリー、市場の促進要因、抑制要因、市場動向、主要企業分析などの情報をお届けいたします。

Clinical Trial Imaging – our new study reveals trends, R&D progress, and predicted revenuesWhere is the Clinical Trial Imaging market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2029, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 186-page report provides 33 tables, 113 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Clinical Trial Imaging market. See how to exploit the opportunities.
Forecasts to 2029 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2029, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 2 segmentations of the Clinical Trial Imaging market, with forecasts for 6 Modalities, and 6 End Users, each forecasted at a global and regional level.
Global Clinical Trial Imaging Market by Modality
• Computed Tomography
• Echocardiography
• Magnetic Resonance Imaging
• Positron Emission Tomography
• Ultrasound
• X-Ray
• Other Modalities
Global Clinical Trial Imaging Market by End Users
• Academic and Government Research Institutes
• Biotechnology Companies
• Contract Research Organizations
• Medical Device Manufacturers
• Pharmaceutical Companies
• Other End Users
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 regional and 17 leading national markets:
• North America:
• US
• Canada
• Latin America:
• Brazil
• Mexico
• Rest of Latin America
• Western Europe:
• Germany
• The UK
• Italy
• France
• Spain
• Nordic
• Benelux
• Rest of Western Europe
• Eastern Europe:
• Russia
• Poland
• Rest of Eastern Europe
• Asia-Pacific:
• Japan
• China
• India
• Australia & New Zealand
• ASEAN
• Rest of Asia-Pacific
• MEA:
• GCC Countries
• South Africa
• Northern Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Clinical Trial Imaging market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, Russia, Germany and China in particular, will continue to achieve high revenue growth to 2029.
Leading companies and the potential for market growth
Overall world revenue for Clinical Trial Imaging will surpass $818.36 million in 2019, our work calculates. We predict strong revenue growth through to 2029.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Clinical Trial Imaging Market report helps you
In summary, our 253-page report provides you with the following knowledge:
• Revenue forecasts to 2029 for 2 segmentations of the Clinical Trial Imaging market, with forecasts for 6 Modalities, and 6 End Users, each forecasted at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2029 for 6 regional and 21 key national markets – See forecasts for the Clinical Trial Imaging market in North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, the UK, Italy, France, Nordic Countries, Benelux, China, India, Japan, Australia & New Zealand, ASEAN countries, GCC Countries, South Africa and Northern Africa.
• Stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Clinical Trial Imaging market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Clinical Trial Imaging Sequencing market and leading companies. You will find data, trends and predictions.
Get our report today The Clinical Trial Imaging Market Forecast 2017-2027: Revenue Prospects by Modality (Computed Tomography, Echocardiography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, X-Ray, Other Modalities), End Users (Academic and Government Research Institutes, Biotechnology Companies, Contract Research Organizations, Medical Device Manufacturers, Pharmaceutical Companies, Other End Users), and Geography.

【レポートの目次】

1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain

2. Clinical Trial Imaging Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Global Clinical Trial Imaging Market Size and Forecast
2.3. Market Dynamics
2.3.1. Market Drivers
2.3.1.1. Growth in The Pharmaceutical and Biotechnology Industries
2.3.1.2. Increase in R&D Spending
2.3.2. Market Restraints
2.3.2.1. High Implementation Cost of Imaging Systems
2.3.3. Market Opportunities
2.3.4. Global Clinical Trial Imaging Market: Trends
2.3.5. Mergers and Acquisitions
2.3.6. Entry of New Market Players

3. Global Clinical Trial Imaging Market Analysis and Forecast, By Modality
3.1. Introduction
3.1.1. Global Clinical Trial Imaging Market, Annual Growth Rate Comparison, By Modality
3.2. Global Clinical Trial Imaging Market Size and Forecast, By Modality
3.2.1. Computed Tomography
3.2.2. Echocardiography
3.2.3. Magnetic Resonance Imaging
3.2.4. Positron Emission Tomography
3.2.5. Ultrasound
3.2.6. X-Ray
3.2.7. Others
3.3. Global Clinical Trial Imaging Attractiveness Index, By Modality

4. Global Clinical Trial Imaging Market Analysis and Forecast, By End Users
4.1. Introduction
4.1.1. Global Clinical Trial Imaging Market, Annual Growth Rate Comparison, By End Users
4.1.2. Global Clinical Trial Imaging Market Share Comparison, By End Users (2018 & 2029)
4.2. Global Clinical Trial Imaging Market Size and Forecast, By End Users
4.2.1. Academic and Government Research Institutes
4.2.2. Biotechnology Companies
4.2.3. Contract Research Organizations
4.2.4. Medical Device Manufacturers
4.2.5. Pharmaceutical Companies
4.2.6. Others
4.3. Global Clinical Trial Imaging Attractiveness Index, By End Users

5. Global Clinical Trial Imaging Market Analysis and Forecast, By Region
5.1. Introduction
5.1.1. Global Clinical Trial Imaging Market, Annual Growth Rate Comparison, By Region
5.1.2. Global Clinical Trial Imaging Market Share Comparison, By Region (2018 & 2029)
5.2. Global Clinical Trial Imaging Market Size and Forecast, By Region
5.2.1. North America (U.S., Canada)
5.2.2. Latin America (Brazil, Mexico, Rest of Latin America)
5.2.3. Western Europe (UK, France, Germany, Italy, Spain, Nordic, Benelux, RoWE)
5.2.4. Eastern Europe (Russia, Poland, Rest of Eastern Europe)
5.2.5. Asia Pacific (Japan, China, India, ASEAN, Australia, RoAPAC)
5.2.6. MEA (GCC, South Africa, North Africa, RoMEA)
5.3. Global Clinical Trial Imaging Market Attractiveness Index, By Region

6. North America Clinical Trial Imaging Market Analysis and Forecast, 2019–2029
6.1. Introduction
6.1.1. North America Clinical Trial Imaging Market
6.1.2. North America Clinical Trial Imaging Market, Annual Growth Rate Comparison, By Country
6.2. North America Clinical Trial Imaging Market Size and Forecast, By Country
6.2.1. The U.S. Clinical Trial Imaging Market
6.2.2. Canada Clinical Trial Imaging Market
6.3. North America Clinical Trial Imaging Market Size and Forecast, By Modality
6.4. North America Clinical Trial Imaging Market Size and Forecast, By End Users
6.5. North America Clinical Trial Imaging Market Attractiveness Index
6.6. North America Clinical Trial Imaging Market Attractiveness Index, By Country
6.7. North America Clinical Trial Imaging Market Attractiveness Index, By Modality
6.8. North America Clinical Trial Imaging Market Attractiveness Index, By End Users

7. Latin America Clinical Trial Imaging Market Analysis and Forecast, 2019–2029
7.1. Introduction
7.1.1. Latin America Clinical Trial Imaging Market
7.1.2. Latin America Clinical Trial Imaging Market, Annual Growth Rate Comparison, By Country
7.2. Latin America Clinical Trial Imaging Market Size and Forecast, By Country
7.2.1. Brazil Clinical Trial Imaging Market
7.2.2. Mexico Clinical Trial Imaging Market
7.2.3. Rest of Latin America Clinical Trial Imaging Market
7.3. Latin America Clinical Trial Imaging Market Size and Forecast, By Modality
7.4. Latin America Clinical Trial Imaging Market Size and Forecast, By End Users
7.5. Latin America Clinical Trial Imaging Market Attractiveness Index
7.6. Latin America Clinical Trial Imaging Market Attractiveness Index, By Country
7.7. Latin America Clinical Trial Imaging Market Attractiveness Index, By Modality
7.8. Latin America Clinical Trial Imaging Market Attractiveness Index, By End Users

8. Western Europe Clinical Trial Imaging Market Analysis and Forecast, 2019–2029
8.1. Introduction
8.1.1. Western Europe Clinical Trial Imaging Market
8.1.2. Western Europe Clinical Trial Imaging Market, Annual Growth Rate Comparison, By Country
8.2. Western Europe Clinical Trial Imaging Market Size and Forecast, By Country
8.2.1. U.K. Clinical Trial Imaging Market
8.2.2. France Clinical Trial Imaging Market
8.2.3. Germany Clinical Trial Imaging Market
8.2.4. Italy Clinical Trial Imaging Market
8.2.5. Spain Clinical Trial Imaging Market
8.2.6. Nordic Clinical Trial Imaging Market
8.2.7. Benelux Clinical Trial Imaging Market
8.2.8. Rest of Western Europe Clinical Trial Imaging Market
8.3. Western Europe Clinical Trial Imaging Market Size and Forecast, By Modality
8.4. Western Europe Clinical Trial Imaging Market Size and Forecast, By End Users
8.5. Western Europe Clinical Trial Imaging Market Attractiveness Index
8.6. Western Europe Clinical Trial Imaging Market Attractiveness Index, By Country
8.7. Western Europe Clinical Trial Imaging Market Attractiveness Index, By Modality
8.8. Western Europe Clinical Trial Imaging Market Attractiveness Index, By End Users

9. Eastern Europe Clinical Trial Imaging Market Analysis and Forecast, 2019–2029
9.1. Introduction
9.1.1. Eastern Europe Clinical Trial Imaging Market
9.1.2. Eastern Europe Clinical Trial Imaging Market, Annual Growth Rate Comparison, By Country
9.2. Eastern Europe Clinical Trial Imaging Market Size and Forecast, By Country
9.2.1. Russia Clinical Trial Imaging Market
9.2.2. Poland Clinical Trial Imaging Market
9.2.3. Rest of Eastern Europe Clinical Trial Imaging Market
9.3. Eastern Europe Clinical Trial Imaging Market Size and Forecast, By Modality
9.4. Eastern Europe Clinical Trial Imaging Market Size and Forecast, By End Users
9.5. Eastern Europe Clinical Trial Imaging Market Attractiveness Index
9.6. Eastern Europe Clinical Trial Imaging Market Attractiveness Index, By Country
9.7. Eastern Europe Clinical Trial Imaging Market Attractiveness Index, By Modality
9.8. Eastern Europe Clinical Trial Imaging Market Attractiveness Index, By End Users

10. Asia Pacific Clinical Trial Imaging Market Analysis and Forecast, 2019–2029
10.1. Introduction
10.1.1. Asia Pacific Clinical Trial Imaging Market
10.1.2. Asia Pacific Clinical Trial Imaging Market, Annual Growth Rate Comparison, By Country
10.2. Asia Pacific Clinical Trial Imaging Market Size and Forecast, By Country
10.2.1. China Clinical Trial Imaging Market
10.2.2. India Clinical Trial Imaging Market
10.2.3. Australia Clinical Trial Imaging Market
10.2.4. ASEAN Clinical Trial Imaging Market
10.2.5. Japan Clinical Trial Imaging Market
10.2.6. Rest of Asia Pacific Clinical Trial Imaging Market
10.3. Asia Pacific Clinical Trial Imaging Market Size and Forecast, By Modality
10.4. Asia Pacific Clinical Trial Imaging Market Size and Forecast, By End Users
10.5. Asia Pacific Clinical Trial Imaging Market Attractiveness Index
10.6. Asia Pacific Clinical Trial Imaging Market Attractiveness Index, By Country
10.7. Asia Pacific Clinical Trial Imaging Market Attractiveness Index, By Modality
10.8. Asia Pacific Clinical Trial Imaging Market Attractiveness Index, By End Users

11. MEA Clinical Trial Imaging Market Analysis and Forecast, 2019–2029
11.1. Introduction
11.1.1. MEA Clinical Trial Imaging Market
11.1.2. MEA Clinical Trial Imaging Market, Annual Growth Rate Comparison, By Country
11.2. MEA Clinical Trial Imaging Market Size and Forecast, By Country
11.2.1. GCC Clinical Trial Imaging Market
11.2.2. South Africa Clinical Trial Imaging Market
11.2.3. North Africa Clinical Trial Imaging Market
11.2.4. Rest of MEA Clinical Trial Imaging Market
11.3. MEA Clinical Trial Imaging Market Size and Forecast, By Modality
11.4. MEA Clinical Trial Imaging Market Size and Forecast, By End Users
11.5. MEA Clinical Trial Imaging Market Attractiveness Index
11.6. MEA Clinical Trial Imaging Market Attractiveness Index, By Country
11.7. MEA Clinical Trial Imaging Market Attractiveness Index, By Modality
11.8. MEA Clinical Trial Imaging Market Attractiveness Index, By End Users

12. Leading Companies in the Clinical Trial Imaging Market
12.1. Competition Dashboard
12.2. Company Share Analysis
12.3. Company Profiling of 25 Major Players
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance (2016-2018)
12.3.4. Recent Initiatives

13. Conclusion

14. Glossary

List of Figures
15.1. Research design
15.2. Market segmentation & scope
15.3. Value chain analysis
15.4. Porter’s Five Forces
15.5. Market summary
15.6. Market driver analysis (Current & Future Impact)
15.7. Market restraint analysis (Current & Future Impact)
15.8. Global Clinical Trial Imaging Market by Modality, 2019-2029 (USD million)
15.9. Global Clinical Trial Imaging Market for Computed Tomography, 2019-2029 (USD million)
15.10. Global Clinical Trial Imaging Market for Echocardiography, 2019-2029 (USD million)
15.11. Global Clinical Trial Imaging Market for Magnetic Resonance Imaging, 2019-2029 (USD million)
15.12. Global Clinical Trial Imaging Market for Positron Emission Tomography, 2019-2029 (USD million)
15.13. Global Clinical Trial Imaging Market for Ultrasound, 2019-2029 (USD million)
15.14. Global Clinical Trial Imaging Market for X-Ray, 2019-2029 (USD million)
15.15. Global Clinical Trial Imaging Market for Others, 2019-2029 (USD million)
15.16. Global Clinical Trial Imaging Market by End Users, 2019-2029 (USD million)
15.17. Global Clinical Trial Imaging Market for Academic and Government Research Institutes, 2019-2029 (USD million)
15.18. Global Clinical Trial Imaging Market for Biotechnology Companies, 2019-2029 (USD million)
15.19. Global Clinical Trial Imaging Market for Contract Research Organizations, 2019-2029 (USD million)
15.20. Global Clinical Trial Imaging Market for Medical Device Manufacturers, 2019-2029 (USD million)
15.21. Global Clinical Trial Imaging Market for Pharmaceutical Companies, 2019-2029 (USD million)
15.22. Global Clinical Trial Imaging Market for Others, 2019-2029 (USD million)
15.23. North America Clinical Trial Imaging Market by Modality, 2019-2029 (USD million)
15.24. North America Clinical Trial Imaging Market for Computed Tomography, 2019-2029 (USD million)
15.25. North America Clinical Trial Imaging Market for Echocardiography, 2019-2029 (USD million)
15.26. North America Clinical Trial Imaging Market for Magnetic Resonance Imaging, 2019-2029 (USD million)
15.27. North America Clinical Trial Imaging Market for Positron Emission Tomography, 2019-2029 (USD million)
15.28. North America Clinical Trial Imaging Market for Ultrasound, 2019-2029 (USD million)
15.29. North America Clinical Trial Imaging Market for X-Ray, 2019-2029 (USD million)
15.30. North America Clinical Trial Imaging Market for Others, 2019-2029 (USD million)
15.31. North America Clinical Trial Imaging Market by End Users, 2019-2029 (USD million)
15.32. North America Clinical Trial Imaging Market for Academic and Government Research Institutes, 2019-2029 (USD million)
15.33. North America Clinical Trial Imaging Market for Biotechnology Companies, 2019-2029 (USD million)
15.34. North America Clinical Trial Imaging Market for Contract Research Organizations, 2019-2029 (USD million)
15.35. North America Clinical Trial Imaging Market for Medical Device Manufacturers, 2019-2029 (USD million)
15.36. North America Clinical Trial Imaging Market for Pharmaceutical Companies, 2019-2029 (USD million)
15.37. North America Clinical Trial Imaging Market for Others, 2019-2029 (USD million)
15.38. Latin America Clinical Trial Imaging Market by Modality, 2019-2029 (USD million)
15.39. Latin America Clinical Trial Imaging Market for Computed Tomography, 2019-2029 (USD million)
15.40. Latin America Clinical Trial Imaging Market for Echocardiography, 2019-2029 (USD million)
15.41. Latin America Clinical Trial Imaging Market for Magnetic Resonance Imaging, 2019-2029 (USD million)
15.42. Latin America Clinical Trial Imaging Market for Positron Emission Tomography, 2019-2029 (USD million)
15.43. Latin America Clinical Trial Imaging Market for Ultrasound, 2019-2029 (USD million)
15.44. Latin America Clinical Trial Imaging Market for X-Ray, 2019-2029 (USD million)
15.45. Latin America Clinical Trial Imaging Market for Others, 2019-2029 (USD million)
15.46. Latin America Clinical Trial Imaging Market by End Users, 2019-2029 (USD million)
15.47. Latin America Clinical Trial Imaging Market for Academic and Government Research Institutes, 2019-2029 (USD million)
15.48. Latin America Clinical Trial Imaging Market for Biotechnology Companies, 2019-2029 (USD million)
15.49. Latin America Clinical Trial Imaging Market for Contract Research Organizations, 2019-2029 (USD million)
15.50. Latin America Clinical Trial Imaging Market for Medical Device Manufacturers, 2019-2029 (USD million)
15.51. Latin America Clinical Trial Imaging Market for Pharmaceutical Companies, 2019-2029 (USD million)
15.52. Latin America Clinical Trial Imaging Market for Others, 2019-2029 (USD million)
15.53. Western Europe Clinical Trial Imaging Market by Modality, 2019-2029 (USD million)
15.54. Western Europe Clinical Trial Imaging Market for Computed Tomography, 2019-2029 (USD million)
15.55. Western Europe Clinical Trial Imaging Market for Echocardiography, 2019-2029 (USD million)
15.56. Western Europe Clinical Trial Imaging Market for Magnetic Resonance Imaging, 2019-2029 (USD million)
15.57. Western Europe Clinical Trial Imaging Market for Positron Emission Tomography, 2019-2029 (USD million)
15.58. Western Europe Clinical Trial Imaging Market for Ultrasound, 2019-2029 (USD million)
15.59. Western Europe Clinical Trial Imaging Market for X-Ray, 2019-2029 (USD million)
15.60. Western Europe Clinical Trial Imaging Market for Others, 2019-2029 (USD million)
15.61. Western Europe Clinical Trial Imaging Market by End Users, 2019-2029 (USD million)
15.62. Western Europe Clinical Trial Imaging Market for Academic and Government Research Institutes, 2019-2029 (USD million)
15.63. Western Europe Clinical Trial Imaging Market for Biotechnology Companies, 2019-2029 (USD million)
15.64. Western Europe Clinical Trial Imaging Market for Contract Research Organizations, 2019-2029 (USD million)
15.65. Western Europe Clinical Trial Imaging Market for Medical Device Manufacturers, 2019-2029 (USD million)
15.66. Western Europe Clinical Trial Imaging Market for Pharmaceutical Companies, 2019-2029 (USD million)
15.67. Western Europe Clinical Trial Imaging Market for Others, 2019-2029 (USD million)
15.68. Eastern Europe Clinical Trial Imaging Market by Modality, 2019-2029 (USD million)
15.69. Eastern Europe Clinical Trial Imaging Market for Computed Tomography, 2019-2029 (USD million)
15.70. Eastern Europe Clinical Trial Imaging Market for Echocardiography, 2019-2029 (USD million)
15.71. Eastern Europe Clinical Trial Imaging Market for Magnetic Resonance Imaging, 2019-2029 (USD million)
15.72. Eastern Europe Clinical Trial Imaging Market for Positron Emission Tomography, 2019-2029 (USD million)
15.73. Eastern Europe Clinical Trial Imaging Market for Ultrasound, 2019-2029 (USD million)
15.74. Eastern Europe Clinical Trial Imaging Market for X-Ray, 2019-2029 (USD million)
15.75. Eastern Europe Clinical Trial Imaging Market for Others, 2019-2029 (USD million)
15.76. Eastern Europe Clinical Trial Imaging Market by End Users, 2019-2029 (USD million)
15.77. Eastern Europe Clinical Trial Imaging Market for Academic and Government Research Institutes, 2019-2029 (USD million)
15.78. Eastern Europe Clinical Trial Imaging Market for Biotechnology Companies, 2019-2029 (USD million)
15.79. Eastern Europe Clinical Trial Imaging Market for Contract Research Organizations, 2019-2029 (USD million)
15.80. Eastern Europe Clinical Trial Imaging Market for Medical Device Manufacturers, 2019-2029 (USD million)
15.81. Eastern Europe Clinical Trial Imaging Market for Pharmaceutical Companies, 2019-2029 (USD million)
15.82. Eastern Europe Clinical Trial Imaging Market for Others, 2019-2029 (USD million)
15.83. Asia Pacific Clinical Trial Imaging Market by Modality, 2019-2029 (USD million)
15.84. Asia Pacific Clinical Trial Imaging Market for Computed Tomography, 2019-2029 (USD million)
15.85. Asia Pacific Clinical Trial Imaging Market for Echocardiography, 2019-2029 (USD million)
15.86. Asia Pacific Clinical Trial Imaging Market for Magnetic Resonance Imaging, 2019-2029 (USD million)
15.87. Asia Pacific Clinical Trial Imaging Market for Positron Emission Tomography, 2019-2029 (USD million)
15.88. Asia Pacific Clinical Trial Imaging Market for Ultrasound, 2019-2029 (USD million)
15.89. Asia Pacific Clinical Trial Imaging Market for X-Ray, 2019-2029 (USD million)
15.90. Asia Pacific Clinical Trial Imaging Market for Others, 2019-2029 (USD million)
15.91. Asia Pacific Clinical Trial Imaging Market by End Users, 2019-2029 (USD million)
15.92. Asia Pacific Clinical Trial Imaging Market for Academic and Government Research Institutes, 2019-2029 (USD million)
15.93. Asia Pacific Clinical Trial Imaging Market for Biotechnology Companies, 2019-2029 (USD million)
15.94. Asia Pacific Clinical Trial Imaging Market for Contract Research Organizations, 2019-2029 (USD million)
15.95. Asia Pacific Clinical Trial Imaging Market for Medical Device Manufacturers, 2019-2029 (USD million)
15.96. Asia Pacific Clinical Trial Imaging Market for Pharmaceutical Companies, 2019-2029 (USD million)
15.97. Asia Pacific Clinical Trial Imaging Market for Others, 2019-2029 (USD million)
15.98. MEA Clinical Trial Imaging Market by Modality, 2019-2029 (USD million)
15.99. MEA Clinical Trial Imaging Market for Computed Tomography, 2019-2029 (USD million)
15.100. MEA Clinical Trial Imaging Market for Echocardiography, 2019-2029 (USD million)
15.101. MEA Clinical Trial Imaging Market for Magnetic Resonance Imaging, 2019-2029 (USD million)
15.102. MEA Clinical Trial Imaging Market for Positron Emission Tomography, 2019-2029 (USD million)
15.103. MEA Clinical Trial Imaging Market for Ultrasound, 2019-2029 (USD million)
15.104. MEA Clinical Trial Imaging Market for X-Ray, 2019-2029 (USD million)
15.105. MEA Clinical Trial Imaging Market for Others, 2019-2029 (USD million)
15.106. MEA Clinical Trial Imaging Market by End Users, 2019-2029 (USD million)
15.107. MEA Clinical Trial Imaging Market for Academic and Government Research Institutes, 2019-2029 (USD million)
15.108. MEA Clinical Trial Imaging Market for Biotechnology Companies, 2019-2029 (USD million)
15.109. MEA Clinical Trial Imaging Market for Contract Research Organizations, 2019-2029 (USD million)
15.110. MEA Clinical Trial Imaging Market for Medical Device Manufacturers, 2019-2029 (USD million)
15.111. MEA Clinical Trial Imaging Market for Pharmaceutical Companies, 2019-2029 (USD million)
15.112. MEA Clinical Trial Imaging Market for Others, 2019-2029 (USD million)
15.113. List of Companies

List of Tables
16.1. Global Clinical Trial Imaging Market, by Modality, 2019-2029 (USD million)
16.2. Global Clinical Trial Imaging Market, by End Users, 2019-2029 (USD million)
16.3. North America Clinical Trial Imaging Market, 2019-2029 (USD million)
16.4. U.S. Clinical Trial Imaging Market, 2019-2029 (USD million)
16.5. Canada Clinical Trial Imaging Market, 2019-2029 (USD million)
16.6. Latin America Clinical Trial Imaging Market, 2019-2029 (USD million)
16.7. Brazil Clinical Trial Imaging Market, 2019-2029 (USD million)
16.8. Mexico Clinical Trial Imaging Market, 2019-2029 (USD million)
16.9. Rest of Latin America Clinical Trial Imaging Market, 2019-2029 (USD million)
16.10. Western Europe Clinical Trial Imaging Market, 2019-2029 (USD million)
16.11. UK Clinical Trial Imaging Market, 2019-2029 (USD million)
16.12. France Clinical Trial Imaging Market, 2019-2029 (USD million)
16.13. Germany Clinical Trial Imaging Market, 2019-2029 (USD million)
16.14. Italy Clinical Trial Imaging Market, 2019-2029 (USD million)
16.15. Nordic Clinical Trial Imaging Market, 2019-2029 (USD million)
16.16. Benelux Clinical Trial Imaging Market, 2019-2029 (USD million)
16.17. Rest of Western Europe Clinical Trial Imaging Market, 2019-2029 (USD million)
16.18. Eastern Europe Clinical Trial Imaging Market, 2019-2029 (USD million)
16.19. Russia Clinical Trial Imaging Market, 2019-2029 (USD million)
16.20. Poland Clinical Trial Imaging Market, 2019-2029 (USD million)
16.21. Rest of Eastern Europe Clinical Trial Imaging Market, 2019-2029 (USD million)
16.22. Asia Pacific Clinical Trial Imaging Market, 2019-2029 (USD million)
16.23. Japan Clinical Trial Imaging Market, 2019-2029 (USD million)
16.24. India Clinical Trial Imaging Market, 2019-2029 (USD million)
16.25. Australia Clinical Trial Imaging Market, 2019-2029 (USD million)
16.26. ASEAN Clinical Trial Imaging Market, 2019-2029 (USD million)
16.27. China Clinical Trial Imaging Market, 2019-2029 (USD million)
16.28. Rest of Asia Pacific Clinical Trial Imaging Market, 2019-2029 (USD million)
16.29. MEA Clinical Trial Imaging Market, 2019-2029 (USD million)
16.30. South Africa Clinical Trial Imaging Market, 2019-2029 (USD million)
16.31. North Africa Clinical Trial Imaging Market, 2019-2029 (USD million)
16.32. GCC Clinical Trial Imaging Market, 2019-2029 (USD million)
16.33. Rest of MEA Clinical Trial Imaging Market, 2019-2029 (USD million)



★調査レポート[臨床試験イメージングの世界市場2019-2029] ( Clinical Trial Imaging Market Report 2019-2029 / VGN910401) 販売に関する免責事項
[臨床試験イメージングの世界市場2019-2029] ( Clinical Trial Imaging Market Report 2019-2029 / VGN910401) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆